PPARA and irritable bowel syndrome: The combined anti-inflammatory effects produced by PPARs, along with the TLR-mediated cytoprotective effects, might be beneficial for inflammatory bowel diseases; however, further clarification is required to explore the microbiota–PPAR–TLR interactions in inflammatory bowel diseases and irritable bowel syndrome.